Archive: March 2016
Feature Article
Role of the Androgen Receptor in Triple-Negative Breast Cancer
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Murtuza Rampurwala, MD, MPH, Kari B. Wisinski, MD, and Ruth O’Regan, MD The authors […]
Feature Article
Approach to the Surgical Management of Resectable Gastric Cancer
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Humair S. Quadri, MD, Young K. Hong, MD, and Waddah B. Al-Refaie, MD The […]
Highlights
Highlights From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 January 7-9, 2016 • San Francisco, California Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer […]
Lung Cancer in Focus
Identifying and Addressing the Toxicity of Checkpoint Inhibitors in Lung Cancer
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Julie R. Brahmer, MD Associate Professor of Medical Oncology Sidney Kimmel Comprehensive Cancer Center […]
Advances in Hematology
Diagnosis and Treatment of Upper Extremity Deep Vein Thrombosis and Thoracic Outlet Syndrome
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Ying-Wei Lum, MD Assistant Professor of Surgery Division of Vascular Surgery and Endovascular Therapy […]
Advances in Drug Development
The Effect on Drug Development of the National Cancer Institute’s Cancer Therapy Evaluation Program
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 James Zwiebel, MD Chief, Investigational Drug Branch Cancer Therapy Evaluation Program National Cancer Institute […]
Advances in LLM
The Use of Ibrutinib in Chronic Lymphocytic Leukemia
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Lloyd E. Damon, MD Clinical Professor, Department of Medicine Director, Hematologic Malignancies and Bone […]
Hem/Onc News
Hem/Onc News
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Devon Schuyler Eribulin Approved for Unresectable or Metastatic Liposarcoma The US Food and Drug […]
Letter From the Editor
Letter From the Editor: Doctors As Writers
Clinical Advances in Hematology & Oncology March 2016, Volume 14, Issue 3 Bruce D. Cheson, MD I write what I write. —Umberto Eco (1932-2016) A few […]